| Cell line name |
HMy.2 B |
|---|
| Synonyms |
LICR-Lon-HMy-2; LICR-LON-HMy2; LICR.LON.HMy2; Licr.Lon.Hmy2; LICRLON/My2; Hmy2; LICR-2 |
|---|
| Accession |
CVCL_8119 |
|---|
| Resource Identification Initiative |
To cite this cell line use: HMy.2 B (RRID:CVCL_8119) |
|---|
| Comments |
Group: Hybridoma fusion partner cell line.
Population: Caucasian.
Doubling time: 24 hours (Patent=US4695538).
Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Cell type: B-cell; CL=CL_0000236. |
|---|
| HLA typing |
Source: IPD-IMGT/HLA=10744
| Class I | | HLA-A | A*02:01 | | HLA-B | B*35:03 | | HLA-C | C*04:01 |
Source: CLS=302008
| Class I | | HLA-A | A*02:01:01,03:01:01 | | HLA-B | B*15:01:01,35:03:01 | | HLA-C | C*03:04:01,04:01:01 | | Class II | | HLA-DP | DPB1*03:01:01,04:01:01 | | HLA-DQ | DQA1*03:01:01,05:05:01 | | DQB1*03:01:01,03:02:01 | | HLA-DR | DRB1*04:01:01,12:01:01 |
|
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Hierarchy |
Parent: CVCL_1072 (ARH-77)
Children:
|
|---|
| Sex of cell |
Female |
|---|
| Age at sampling |
33Y |
|---|
| Category |
Transformed cell line |
|---|
| STR profile |
Source(s): CLS=302008; TKG=TKG 0221
Markers:| Amelogenin | X |
| CSF1PO | 6,10 |
| D2S1338 | 17 |
| D3S1358 | 16 |
| D5S818 | 10,13 |
| D7S820 | 7,12 |
| D8S1179 | 14,15 |
| D13S317 | 11,13 |
| D16S539 | 9,13 (TKG=TKG 0221)
13 (CLS=302008) |
| D18S51 | 4,16 |
| D19S433 | 14,15 |
| D21S11 | 29,30 |
| FGA | 20,21 |
| TH01 | 8,9.3 |
| TPOX | 8 |
| vWA | 17 |
Run an STR similarity search on this cell line |
|---|
| Publications | PubMed=7140810; DOI=10.1002/eji.1830120804
Paul A.W. Edwards, Carissa M. Smith, Alexander Munro Neville, Michael J. O'Hare;
A human-hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line.
Eur. J. Immunol. 12:641-648(1982) PubMed=6350451; DOI=10.4049/jimmunol.131.3.1201
Paul G. Abrams, James A. Knost, Gregory Clarke, Shannon Wilburn, Robert K. Oldham, Kenneth Alan Foon;
Determination of the optimal human cell lines for development of human hybridomas.
J. Immunol. 131:1201-1204(1983) PubMed=6864164; DOI=10.1084/jem.158.1.53; PMCID=PMC2187084
Alan N. Houghton, Hannah Brooks, Richard J. Cote, Michael C. Taormina, Herbert Friedrich Oettgen, Lloyd John Old;
Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.
J. Exp. Med. 158:53-65(1983) DOI=10.1007/978-1-4613-2823-0_29
Abraham Karpas;
Viruses and human leukemia in vitro.
(In book chapter) Human leukemia. Cytochemical and ultrastructural techniques in diagnosis and research. Developments in Oncology, Vol. 14; Polliack, Aaron (eds.); pp.495-526; Martinus Nijhoff Publishing; Boston; USA (1984) PubMed=6582512; DOI=10.1073/pnas.81.2.568; PMCID=PMC344720
Michael Jules Mattes, Carlos Cordon-Cardo, John L. Lewis Jr., Lloyd John Old, Kenneth Oliver Lloyd;
Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.
Proc. Natl. Acad. Sci. U.S.A. 81:568-572(1984) Patent=US4695538
Richard J. Cote, Timothy M. Thomson, Alan N. Houghton, Herbert Friedrich Oettgen, Lloyd John Old, Carlos C. Cardo;
Human monoclonal antibodies to cell surface antigens.
Patent number US4695538, 22-Sep-1987 |
|---|
| Cross-references |
|---|
| Cell line collections (Providers) |
CLS; 302008
TKG; TKG 0221
|
|---|
| Cell line databases/resources |
IPD-IMGT/HLA; 10744
|
|---|
| Encyclopedic resources |
Wikidata; Q54889980
|
|---|
| Entry history |
|---|
| Entry creation | 04-Apr-2012 |
|---|
| Last entry update | 19-Dec-2024 |
|---|
| Version number | 23 |
|---|
